Caberlact 0.25mg 2 Tablets

Babies: It is not safe for babies. Lactating mothers: Cabergoline or its metabolites are excreted in milk in rats.
There is no information on the excretion of cabergoline in human breast milk. However, mothers should be advised not to breastfeed in the event of failed lactation inhibition/suppression by cabergoline.
Cabergoline should not be given to mothers with hyperprolactinemic disorders who want to breastfeed their children because it inhibits lactation. Pregnancy: Cabergoline is generally thought to be safe to use during pregnancy.
Animal studies have revealed that there are few or no adverse effects on the developing baby. However, there are limited human data.
Driving: Cabergoline capsules may impair your alertness, impair your vision, or make you sleepy and dizzy. If you experience any of these symptoms, do not drive.
Alcohol: Avoid consumption of alcohol while taking cabergoline capsules as it increases the risk of dizziness. Liver: Cabergoline tablets should be used in caution with patients suffering from liver disease.
You may require a dose adjustment and regular monitoring of liver function. Seek doctor advice before using this medication.
Kidney: Cabergoline tablets should be used in caution with patients suffering from kidney disease. You may require a dose adjustment and regular monitoring of kidney function.
Seek a doctor's advice before using this medication. .

Headache Dizziness Nausea Fatigue Syncope Peripheral oedema Hot flashes Palpitations Vertigo Depression Anxiety Insomnia Nervousness Acne Pruritus Breast pain Dysmenorrhea Constipation Abdominal pain Dyspepsia Vomiting Diarrhoea Flatulence Throat irritation Toothache Anorexia Abnormal vision Pain Rhinitis.